Journal of Global Infectious DiseasesOfficial Publishing of INDUSEM and OPUS 12 Foundation, Inc. Users online:415  
Print this pageEmail this pageSmall font sizeDefault font sizeIncrease font size     
Home About us Editors Ahead of Print Current Issue Archives Search Instructions Subscribe Advertise Login 
 

    Article Cited by others

SYMPOSIUM

Combination vaccines

Skibinski David AG, Baudner Barbara C, Singh Manmohan, O«SQ»Hagan Derek T

Year : 2011| Volume: 3| Issue : 1 | Page no: 63-72

   This article has been cited by
 
1 A combined inactivated cholera and hepatitis A vaccine-induced potent protective immunity in a mouse model
Nourhan H. AbdelAllah, Ahmed F. Azmy, Mohamed E. Rashed, Sameh AbdelGhani, Yasser Gaber
Applied Microbiology and Biotechnology. 2022;
[Pubmed]  [Google Scholar] [DOI]
2 Separation of three strains of polio virus by capillary zone electrophoresis and study of their interaction with aluminum oxyhydroxide.
Camille Malburet, Laurent Leclercq, Jean-François Cotte, Jérôme Thiebaud, Hervé Cottet
Journal of Chromatography A. 2022; : 462838
[Pubmed]  [Google Scholar] [DOI]
3 Proposal for the revision of guidelines for clinical trials of vaccines to prevent infectious diseases in Japan
Yumiko Nomura, Kiyohito Noda, Yuusuke Oohashi, Shin Okuda, Jun Matsumoto, Takashi Nakano, Nao Tsuchida, Ken J. Ishii, Kunihiko Hayashi, Tatsuo Iiyama, Hiroshi Onodera, Koji Ishii, Mayumi Shikano, Nobuhiko Okabe
Vaccine. 2022;
[Pubmed]  [Google Scholar] [DOI]
4 Surveillance on the adverse events following immunization with the pentavalent vaccine in Zhejiang, China
Xuejiao Pan, Huakun Lv, Hui Liang, Ying Wang, Linzhi Shen, Fuxing Chen, Yaping Chen, Yu Hu
Human Vaccines & Immunotherapeutics. 2022; : 1
[Pubmed]  [Google Scholar] [DOI]
5 Theories-based determinants analysis of Hib-combined vaccine hesitancy in China: A multi-group structural equation modeling
Xuewen Jiang, Junfen Lin, Wei Wang, Yanrong Zhao, Yinwei Qiu
Human Vaccines & Immunotherapeutics. 2022;
[Pubmed]  [Google Scholar] [DOI]
6 A phase I, open label, clinical study to assess the safety and immunogenicity of indigenously developed liquid (DTwP-HepB-IPV-Hib) hexavalent combination vaccine in healthy toddlers aged 16–24 months
Hitt Sharma, Sanjay Lalwani, Sameer Parekh, Pramod Pujari, Sunil Shewale, Sonali Palkar, Neeta Hanumante, Shilpa Gokhale, Jaganathan KS, Rakesh Kumar, Inderjit Sharma, Sunil Gairola
Human Vaccines & Immunotherapeutics. 2022;
[Pubmed]  [Google Scholar] [DOI]
7 Co-administration of Oral Cholera Vaccine With Oral Polio Vaccine Among Bangladeshi Young Children: A Randomized Controlled Open Label Trial to Assess Interference
Md Taufiqul Islam, Kashmira Date, Ashraful Islam Khan, Taufiqur Rahman Bhuiyan, Zahid Hasan Khan, Shamim Ahmed, Motaher Hossain, Fatema Khaton, K Zaman, Nigel A J McMillan, Abhijeet Anand, Qian An, Chenhua Zhang, William C Weldon, Alexander Yu, Stephen Luby, Firdausi Qadri
Clinical Infectious Diseases. 2022;
[Pubmed]  [Google Scholar] [DOI]
8 Improving Innovation and Access to Combination Vaccines for Childhood Immunization in China
Jiyan Ma, Zhuo Li, Yinuo Sun, Zuokun Liu, Yuan Dang, Yangmu Huang
International Journal of Environmental Research and Public Health. 2022; 19(23): 15557
[Pubmed]  [Google Scholar] [DOI]
9 Peculiarities of Zika Immunity and Vaccine Development: Lessons from Dengue and the Contribution from Controlled Human Infection Model
Helton C. Santiago, Tertuliano A. Pereira-Neto, Marcela H. Gonçalves-Pereira, Ana C. B. Terzian, Anna P. Durbin
Pathogens. 2022; 11(3): 294
[Pubmed]  [Google Scholar] [DOI]
10 COVID-19 and Seasonal Influenza Vaccination: Cross-Protection, Co-Administration, Combination Vaccines, and Hesitancy
Alexander Domnich, Andrea Orsi, Carlo-Simone Trombetta, Giulia Guarona, Donatella Panatto, Giancarlo Icardi
Pharmaceuticals. 2022; 15(3): 322
[Pubmed]  [Google Scholar] [DOI]
11 Age Structured Mathematical Modeling Studies on COVID-19 with respect to Combined Vaccination and Medical Treatment Strategies
Bishal Chhetri, D. K. K. Vamsi, D. Bhanu Prakash, S. Balasubramanian, Carani B. Sanjeevi
Computational and Mathematical Biophysics. 2022; 10(1): 281
[Pubmed]  [Google Scholar] [DOI]
12 Recommendation for use of diphtheria and tetanus toxoids and acellular pertussis, inactivated poliovirus, Haemophilus influenzae type b conjugate, and hepatitis B vaccine in infants
Hye-Kyung Cho, Su Eun Park, Yae-Jean Kim, Dae Sun Jo, Yun-Kyung Kim, Byung-Wook Eun, Taek-Jin Lee, Jina Lee, Hyunju Lee, Ki Hwan Kim, Eun Young Cho, Jong Gyun Ahn, Eun Hwa Choi
Clinical and Experimental Pediatrics. 2021; 64(12): 602
[Pubmed]  [Google Scholar] [DOI]
13 The study of the therapeutic effectiveness of the associated inactivated and subunit vaccines based on Candida albicans and Candida tropicalis fungi
Mykola Rybalkin, Natalia Khokhlenkova, Yuliia Azarenko, Olha Kaliuzhnaia, Illya Podolsky
Pharmacia. 2021; 68(1): 89
[Pubmed]  [Google Scholar] [DOI]
14 Life-Course Approach to Vaccination in Bangladesh for Meeting the Health and Health-Related Sustainable Development Goals: A Commentary
Taufiqur Rahman Bhuiyan, Taufiqul Islam, Firdausi Qadri
The Journal of Infectious Diseases. 2021; 224(Supplement): S749
[Pubmed]  [Google Scholar] [DOI]
15 Hexavalent vaccines in infants: a systematic literature review and meta-analysis of the solicited local and systemic adverse reactions of two hexavalent vaccines
Piyali Mukherjee, Essè Ifèbi Hervé Akpo, Anastasia Kuznetsova, Markus Knuf, Sven-Arne Silfverdal, Pope Kosalaraksa, Attila Mihalyi
Expert Review of Vaccines. 2021; 20(3): 319
[Pubmed]  [Google Scholar] [DOI]
16 Immunogenicity and protection efficacy of enhanced fitness recombinant Salmonella Typhi monovalent and bivalent vaccine strains against acute toxoplasmosis
Fei-Kean Loh, Sheila Nathan, Sek-Chuen Chow, Chee-Mun Fang
Pathogens and Global Health. 2021; 115(6): 392
[Pubmed]  [Google Scholar] [DOI]
17 DTaP combination vaccine use and adherence: A retrospective cohort study
Matthew M. Loiacono, Vitali Pool, Robertus van Aalst
Vaccine. 2021; 39(7): 1064
[Pubmed]  [Google Scholar] [DOI]
18 Was Aldo Castellani the inventor of combined and polyvalent vaccines?
Luca Borghi, Elisabetta Riva
Vaccine. 2021; 39(38): 5442
[Pubmed]  [Google Scholar] [DOI]
19 Nanotechnology for making a paradigm shift in COVID-19 vaccine
Dibya Sundar Panda
Clinical Complementary Medicine and Pharmacology. 2021; : 100017
[Pubmed]  [Google Scholar] [DOI]
20 Impact of combination MMRV vaccine on first-dose coverage for measles and varicella: a population-based study
Shannon E. MacDonald, Suzanne Tough, Xiaoyan Guo, James D. Kellner
Journal of Public Health. 2020;
[Pubmed]  [Google Scholar] [DOI]
21 Co-administration of vaccines: a focus on tetravalent Measles-Mumps-Rubella-Varicella (MMRV) and meningococcal C conjugate vaccines
Paolo Bonanni, Sara Boccalini, Angela Bechini, Ornella Varone, Giulio Matteo, Federica Sandri, Giovanni Gabutti
Human Vaccines & Immunotherapeutics. 2020; 16(6): 1313
[Pubmed]  [Google Scholar] [DOI]
22 Immunogenicity and safety of a combined DTPa-IPV/Hib vaccine administered as a three-dose primary vaccination course and a booster dose in healthy children in Russia: a phase III, non-randomized, open-label study
Victor Romanenko, Irina Osipova, Anna Galustyan, Michael Scherbakov, Nathalie Baudson, Déborah Farhi, Luis Anaya, Sherine O. Kuriyakose, Nadia Meyer, Winnie Janssens
Human Vaccines & Immunotherapeutics. 2020; 16(9): 2265
[Pubmed]  [Google Scholar] [DOI]
23 Landscape of vaccine access and health technology assessment role in decision-making process in ASEAN countries
Suthira Taychakhoonavudh, Woralak Chumchujan, Raymond Hutubessy, Nathorn Chaiyakunapruk
Human Vaccines & Immunotherapeutics. 2020; 16(7): 1728
[Pubmed]  [Google Scholar] [DOI]
24 Protection against fowl cholera in ducks immunized with a combination vaccine containing live attenuated duck enteritis virus and recombinant outer membrane protein H of Pasteurella multocida
Nisachon Apinda, Boondarika Nambooppha, Amarin Rittipornlertrak, Pallop Tankaew, Veerasak Punyapornwithaya, Venugopal Nair, Takuo Sawada, Nattawooti Sthitmatee
Avian Pathology. 2020; 49(3): 221
[Pubmed]  [Google Scholar] [DOI]
25 Efficacy, safety, and formulation issues of the combined vaccines
Say-yed Hesameddin Tafreshi
Expert Review of Vaccines. 2020; 19(10): 949
[Pubmed]  [Google Scholar] [DOI]
26 Combined vaccines for prophylaxis of infectious conditions
Pravin Shende, Mansi Waghchaure
Artificial Cells, Nanomedicine, and Biotechnology. 2019; 47(1): 695
[Pubmed]  [Google Scholar] [DOI]
27 Studies on formulation of a combination heat killed immunogen from diarrheagenic Escherichia coli and Vibrio cholerae in RITARD model
Priyadarshini Mukherjee, Vivek Mondal, Ushasi Bhaumik, Ritam Sinha, Sounak Sarkar, Soma Mitra, Debaki Ranjan Howlader, Suhrid Maiti, Asish Kumar Mukhopadhyay, Shanta Dutta, Hemanta Koley
Microbes and Infection. 2019; 21(8-9): 368
[Pubmed]  [Google Scholar] [DOI]
28 Dual Plug-and-Display Synthetic Assembly Using Orthogonal Reactive Proteins for Twin Antigen Immunization
Karl D. Brune, Can M. Buldun, Yuanyuan Li, Iona J. Taylor, Florian Brod, Sumi Biswas, Mark Howarth
Bioconjugate Chemistry. 2017; 28(5): 1544
[Pubmed]  [Google Scholar] [DOI]
29 A Conjugate Vaccine Using Enantiopure Hapten Imparts Superior Nicotine-Binding Capacity
Jonathan W. Lockner, Jenny M. Lively, Karen C. Collins, Janaína C. M. Vendruscolo, Marc R. Azar, Kim D. Janda
Journal of Medicinal Chemistry. 2015; 58(2): 1005
[Pubmed]  [Google Scholar] [DOI]
30 Preparation and testing of a Haemophilus influenzae Type b/Hepatitis B surface antigen conjugate vaccine
So Jung An, Joo Sung Woo, Myung Hwa Chae, Sudeep Kothari, Rodney Carbis
Vaccine. 2015; 33(13): 1614
[Pubmed]  [Google Scholar] [DOI]
31 Booster Vaccination: The Role of Reduced Antigen Content Vaccines as a Preschool Booster
Giovanni Gabutti,Cecilia Trucchi,Michele Conversano,Giambattista Zivelonghi,Giorgio Zoppi
BioMed Research International. 2014; 2014: 1
[Pubmed]  [Google Scholar] [DOI]
32 What can we learn from the microbial ecological interactions associated with polymicrobial diseases?
J.F. Antiabong,W. Boardman,A.S. Ball
Veterinary Immunology and Immunopathology. 2013;
[Pubmed]  [Google Scholar] [DOI]
33 DTaP-IPV-Hep B-Hib vaccine (Hexyon®/Hexacima®): a guide to its use in the primary and booster vaccination of infants and toddlers in Europe
Katherine A. Lyseng-Williamson,Paul L. McCormack
Drugs & Therapy Perspectives. 2013; 29(11): 329
[Pubmed]  [Google Scholar] [DOI]
34 DTaP-IPV-Hep B-Hib Vaccine (Hexaxim®)
Paul L. McCormack
Pediatric Drugs. 2013; 15(1): 59
[Pubmed]  [Google Scholar] [DOI]
35 Modern Subunit Vaccines: Development, Components, and Research Opportunities
Peter Michael Moyle,Istvan Toth
ChemMedChem. 2013; 8(3): 360
[Pubmed]  [Google Scholar] [DOI]
36 Modern Subunit Vaccines: Development, Components, and Research Opportunities
Moyle, P.M. and Toth, I.
ChemMedChem. 2013; 8(3): 360-376
[Pubmed]  [Google Scholar]
37 DTaP-IPV-Hep B-Hib vaccine (Hexaxim®): A review of its use in primary and booster vaccination
McCormack, P.L.
Pediatric Drugs. 2013; 15(1): 59-70
[Pubmed]  [Google Scholar]
38 Perspectives on optimization of vaccination and immunization of ethiopian children/women: What should and can we further do? why and how?
Gebremariam, M.B.
Ethiopian Medical Journal. 2012; 50(2): 167-184
[Pubmed]  [Google Scholar]

 

Read this article
Sitemap | What's New | Feedback | Copyright and Disclaimer | Privacy Notice | Contact Us
© 2008 Journal of Global Infectious Diseases | Published by Wolters Kluwer - Medknow
Online since 10th December, 2008